Plasma derived medicinal products play a key and often unique role in the treatment of many acute and chronic pathologies.
Self-sufficiency rates of the plasma derived medicinal products
National data year 2024
Albumin
Antithrombin
Immunoglobulins for intravenous use
Immunoglobulin for subcutaneous use
Factor VIII
Factor VIII / Factor von Willebrand
S/D virus-inactivated plasma
Factor IX
3-Factor Prothrombin complex concentrates
Fibrinogen
4-Factor Prothrombin complex concentrates
Activated Prothrombin Complex Concentrates
Protein C
Alpha-1 Antitrypsin
*100% of total demand for contract-manufactured products
Plasma provided to industry 2000-2024
For monthly tracking data click here
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2026
Italian Plasma sent to the industry by category
Apheresis plasmaRecovered plasma
Source:
Adapted by the CNS on data sent by the fractionation Companies, January 2026
